St Jude Medical Inc

Type: Company
Name: St Jude Medical Inc (St. Jude Medical Inc)
Nationality: United States
Web Address: http://www.sjm.com/
Fact Sheet: Fact Sheet for St. Jude Medical Inc
First reported 14 hours ago - Updated 14 hours ago - 1 reports

St. Jude Medical Receives CE Mark for Ilumien Optis PCI System

St. Jude Medical (ST. Paul, MN) received approval from the European Union for its Ilumien Optis PCI optimization system. The new system is designed to model the blood vessels of patients suffering from coronary artery disease. The system can also assist ... [Published QMED - 14 hours ago]
First reported 15 hours ago - Updated 15 hours ago - 1 reports
Frito-Lay
Frito-Lay

Plano Texas Executive Suites Reviews

- Centrally located in North Dallas on Hwy. 190 (George Bush Freeway) between Hwy. 75 and Dallas Tollway in the Parkway Commons building. This building is at the intersection of Preston Road and Plano Parkway. Access to a highly-educated workforce is ... [Published Prlog - 15 hours ago]
First reported 17 hours ago - Updated 17 hours ago - 1 reports
Guidant Corporation
Guidant Corporation

K2M names new executive vice president of global sales

6 minutes ago, 4:51pm (ET) 05/17/2013 DatamonitorK2M, Inc., a spinal device company developing solutions for the treatment of complex spinal pathologies and minimally invasive procedures, has announced the promotion of Gianluca Iasci to the position of ... [Published Zecco - 17 hours ago]
First reported 21 hours ago - Updated 21 hours ago - 1 reports

St Jude Medical: The Winning Streak Continues (STJ)

Shares of St Jude Medical (NYSE:STJ) traded at a new 52-week high today of $47.16. So far today approximately 798,000 shares have been exchanged, as compared to an average 30-day volume of 2.3 million shares.St. Jude Medical, Inc. develops, manufactures, ... [Published Comtex SmarTrend - 21 hours ago]
First reported May 17 2013 - Updated May 17 2013 - 1 reports

St. Jude Medical meldet Europazulassung für 3D-Gefäßrekonstruktionstechnologie zur Unterstützung von Stent-Implantationen

Zukunftswegweisendes System ermöglicht 360-Grad-Panoramadarstellung der Arterien in 3DSt. Jude Medical, Inc. (NYSE:STJ), ein weltweit tätiges Medizintechnik-Unternehmen, gab heute die CE-Zulassung seines ILUMIEN OPTIS PCI Optimization System bekannt. ... [Published FinanzNachrichten.de - May 17 2013]
First reported May 16 2013 - Updated May 17 2013 - 8 reports

St Jude Medical receives approval for Ilumien Optis to treat CAD

St. Jude Medical has received CE Mark approval for its Ilumien Optis Percutaneous Coronary Intervention (PCI) Optimization System.PCI, also known as coronary angioplasty, is a non-surgical procedure designed to provide disease assessment tool for treating ... [Published Medical Devices Business Review - May 17 2013]
First reported May 17 2013 - Updated May 17 2013 - 1 reports
St Jude Medical Inc
St Jude Medical Inc

St. Jude Medical profit tops view, forex to hurt revenue

Seeded by View Original Article: NBCNews.com ... [Published Newsvine - May 17 2013]
First reported May 17 2013 - Updated May 17 2013 - 1 reports

Innovations in Electronics Manufacturing for Medical Devices

Electronic medical device manufacturers are under constant pressure to deliver innovative products on time and within budget, while contending with rapidly changing technologies, increasing product complexity, and strict compliance and safety standards ... [Published ConnectorSupplier.com - May 17 2013]
First reported May 16 2013 - Updated May 16 2013 - 1 reports

OCT imaging market led by Carl Zeiss and St. Jude Medical

The optical coherence tomography imaging market (OCT) is estimated to have reached a valuation of $645.4 million by the end of 2012, increasing from approximately $525.7 million in 2010.Optical coherence tomography is an optical signal acquisition and ... [Published MyNewsDesk - May 16 2013]
First reported May 16 2013 - Updated May 16 2013 - 1 reports

Potential St Jude Medical (STJ) Trade Has 3.01% Downside Protection

St. Jude Medical Inc. (NYSE: STJ) closed Wednesday's trading session at $46.57. In the past year, the stock has hit a 52-week low of $30.25 and 52-week high of $46.64. St Jude Medical (STJ) stock has been showing support around $45.62 and resistance in ... [Published MarketIntelligenceCenter.com - May 16 2013]
First reported May 16 2013 - Updated May 16 2013 - 2 reports

St Jude Medical enrolls first patient in EnligHTN III renal denervation study

St Jude Medical : 16 May, 2013 (Company News)St Jude Medical is enrolling the first patient in the EnligHTN III trial which will evaluate the safety and performance of the new second-generation EnligHTN Renal Denervation System in patients with drug-resistant, ... [Published Pro Health Service Zone - May 16 2013]
First reported May 16 2013 - Updated May 16 2013 - 1 reports

Vascular Solutions Announces Re-Launch of Venture Catheter

Catheter previously offered by St. Jude Medical is once again availableMay 15, 2013 — Vascular Solutions Inc. announced that it has re-launched the Venture catheter, a deflectable-tip catheter used to provide guidewire directional control in challenging ... [Published Diagnostic & Invasive Cardiology - May 16 2013]

Quotes

Major added, "Since joining K2M, Gianluca has been instrumental in establishing and expanding direct sales operations in the UK, Germany, Switzerland, Austria, Italy and Scandinavia, as well as our business in Spain, Australia, New Zealand, Japan and the Middle East. The global alignment of our sales organization under Gianluca in this new, unified role is an important milestone in K2M's strategic plan to become the worldwide leader in complex spine and minimally invasive technologies."
K2M names new executive vice president of global sales [Published Zecco - 17 hours ago]
...on HeartMate II support, either while they wait for a transplant or as a long-term, destination therapy," CEO Gary Burbach said in a statement. "The launch of the Pocket Controller provides an attractive option for these patients and advances Thoratec's mission, which is to improve the lives of individuals suffering from advanced heart failure."
Thoratec wins FDA nod for HeartMate controller [Published FiercePharma - 20 hours ago]
...mit koronarer Herzkrankheit führen", sagte Frank J Callaghan, President der Division Cardiovascular and Ablation Technologies bei St Jude Medical. "Dieses zukunftsweisende System liefert dem Arzt entscheidende Informationen zu Ort und Schweregrad der Erkrankung innerhalb der Koronararterie, und dies kann zu einer besseren medizinischen Entscheidungsfindung und zu einer insgesamt kosteneffizienten Behandlung beitragen."
St. Jude Medical meldet Europazulassung für 3D-Gefäßrekonstruktionstechnologie zur Unterstützung ... [Published FinanzNachrichten.de - May 17 2013]
St Jude MedicalJude Medical Cardiovascular and Ablation Technologies Division president Frank Callaghan said, "This next-generation system delivers critical information to physicians about the location and severity of disease within the coronary arteries, potentially resulting in better medical decision-making and overall cost-effective treatment."
St Jude Medical receives approval for Ilumien Optis to treat CAD [Published Medical Devices Business Review - May 17 2013]

More Content

All (737) | News (405) | Reports (16) | Blogs (71) | Audio/Video (0) | Fact Sheets (5) | Press Releases (239)
sort by: Date | Relevance
St. Jude Medical Receives CE Mark for Ilumien O... [Published QMED - 14 hours ago]
Plano Texas Executive Suites Reviews [Published Prlog - 15 hours ago]
K2M names new executive vice president of globa... [Published Zecco - 17 hours ago]
Thoratec wins FDA nod for HeartMate controller [Published FiercePharma - 20 hours ago]
CE Mark for STJ's ILUMIEN OPTIS Zacks [Published Yahoo! Finance - 21 hours ago]
St Jude Medical: The Winning Streak Continues (... [Published Comtex SmarTrend - 21 hours ago]
St. Jude Medical meldet Europazulassung für 3D-... [Published FinanzNachrichten.de - May 17 2013]
St Jude Medical receives approval for Ilumien O... [Published Medical Devices Business Review - May 17 2013]
St. Jude’s assessment tool gets nod in Europe [Published Cardiovascular Business - May 17 2013]
St. Jude Medical profit tops view, forex to hur... [Published Newsvine - May 17 2013]
Vascular Files Patent Infringement Complaint Ag... [Published BioMedReports - May 17 2013]
Innovations in Electronics Manufacturing for Me... [Published ConnectorSupplier.com - May 17 2013]
St. Jude snags CE mark for 3-D stent imaging [Published FiercePharma - May 16 2013]
St. Jude Medical wins EU green light for Ilumie... [Published MassDevice - May 16 2013]
Molecular Diagnostics Market Expected to Grow a... [Published SBWire - May 16 2013]
OCT imaging market led by Carl Zeiss and St. Ju... [Published MyNewsDesk - May 16 2013]
US EQUITIES OPENING HEADLINES INCLUDING: Genera... [Published Proactiveinvestors United Kingdom RSS feed - May 16 2013]
Global Molecular Diagnostics Market 2012-2016 [Published MarketResearch.com - May 16 2013]
St. Jude Medical Announces European Approval of... [Published Equities.com - May 16 2013]
St. Jude (STJ) Receives CE Mark for LUMIEN OPTI... [Published Street Insider - May 16 2013]
St. Jude Announces CE Mark Approval For Ilumien... [Published RTTNews.com - May 16 2013]
Equities Research Analysts’ Price Target Change... [Published American Banking News - May 16 2013]
St. Jude Medical Announces European Approval of... [Published Benzinga.com - May 16 2013]
St. Jude Medical Announces European Approval of... [Published Business Wire Photo/Multimedia News - May 16 2013]
St. Jude Medical Announces European Approval of... [Published Business Wire Science: Science News - May 16 2013]
St. Jude Medical Announces European Approval of... [Published Business Wire Technology News - May 16 2013]
St. Jude Medical Announces European Approval of... [Published Business Wire Health News - May 16 2013]
St. Jude Medical Announces European Approval of... [Published Business Wire News with Multimedia - May 16 2013]
Potential St Jude Medical (STJ) Trade Has 3.01%... [Published MarketIntelligenceCenter.com - May 16 2013]
Photomedex Upgraded to “Outperform” at Zacks (P... [Published Mideast Time - May 16 2013]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
Daniel J Starks, Lucius Cornelius Sulla, Matthew Taylor, [more]
  •  
New York Stock Exchange, Rigrodsky & Long, Lieff Cabraser Heimann & Bernstein LLP, [more]
  •  
European Union, Heart Rhythm Society, United States District Court for the District o..., [more]
  •  
Patient, Class Action, Pacemaker, [more]
  •  
CE-mark, S&P 500, Libra, [more]
  •  
Saint Paul (Minnesota, United States), San Francisco (United States), Amarillo (United States), [more]
  •  
United States, Japan, India, [more]
  •  
Financial Reporting, Medicine, Internet & IT, [more]
  •  
Health, Pharma & Biotech, Banking & Financial Services, [more]
Business Wire Health News, MarketIntelligenceCenter.com, Individual.com, [more]
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Potential St Jude Medical (STJ) Trade Has 3.01%... [Published MarketIntelligenceCenter.com - May 16 2013]
St. Jude Medical Inc. (NYSE: STJ) closed Wednesday's trading session at $46.57. In the past year, the stock has hit a 52-week low of $30.25 and 52-week high of $46.64. St Jude Medical (STJ) stock has been showing support around $45.62 and resistance in ...
St Jude Medical (STJ) Showing Bullish Technical... [Published MarketIntelligenceCenter.com - May 10 2013]
St. Jude Medical Inc. (NYSE: STJ) closed Thursday's trading session at $43.10. In the past year, the stock has hit a 52-week low of $30.25 and 52-week high of $43.76. St Jude Medical (STJ) stock has been showing support around $41.93 and resistance in ...
Analysts: Buy United Technologies Now and 3 Oth... [Published Wall St. Cheat Sheet - May 02 2013]
United Technologies ( NYSE:UTX ): Atlantic Equities sees current weakness as a buying opportunity, noting that the company is well positioned to generate EPS CAGR of at least 12 percent to 14 percent, over the next several years. It rates the shares at ...
Analysts: Buy United Technologies Now and 3 Oth... [Published Wall St. Cheat Sheet - May 02 2013]
United Technologies ( NYSE:UTX ): Atlantic Equities sees current weakness as a buying opportunity, noting that the company is well positioned to generate EPS CAGR of at least 12 percent to 14 percent, over the next several years. It rates the shares ...
St Jude Medical (STJ) Showing Neutral Technical... [Published MarketIntelligenceCenter.com - May 01 2013]
St. Jude Medical Inc. (NYSE: STJ) closed Tuesday's trading session at $41.22. In the past year, the stock has hit a 52-week low of $30.25 and 52-week high of $43.76. St Jude Medical (STJ) stock has been showing support around $40.57 and resistance in ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
St. Jude Medical Announces European Approval of... [Published Business Wire Photo/Multimedia News - May 16 2013]
St. Jude Medical Announces European Approval of... [Published Business Wire Science: Science News - May 16 2013]
St. Jude Medical Announces European Approval of... [Published Business Wire Technology News - May 16 2013]
St. Jude Medical Announces European Approval of... [Published Business Wire Health News - May 16 2013]
St. Jude Medical Announces European Approval of... [Published Business Wire News with Multimedia - May 16 2013]
1 2 3 4 5 6 7 8 9 10 ...
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.